Sinofert Holdings Limited

Sinofert Holdings Limited, an investment holding company, engages in the production, import and export, distribution, and retail of fertilizer raw materials and finished products primarily in Mainland China and Macao Special Administrative Region. The company operates through Basic Fertilizers, Distribution, and Production segments. It offers nitrogen, phosphate, and potash; compound fertilizers; and monocalcium/dicalcium phosphate. The company also provides technological research and development, and services relating to the fertilizer business and products; develops agriculture products; and manufactures and sells feed stuffs. In addition, it explores for and exploits phosphate mine. The company was founded in 1993 and is based in Wan Chai, Hong Kong. Sinofert Holdings Limited is a subsidiary of Syngenta Group (HK) Holdings Company Limited.

Sinofert Holdings Limited trades as SNFRY on OTC. The company is classified in Basic Materials / Agricultural Inputs and reports in USD.

The current profile places the business in Agricultural Inputs. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $22.63B of revenue and $1.23B of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Sinofert Holdings Limited can be compared against peers such as Altius Minerals Corporation, Perenti Limited, Corbion N.V., C.Uyemura & Co.,Ltd., Elementis plc, Lee & Man Paper Manufacturing Limited.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $1.18B, beta of 0.76, and return on equity of +10.9%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

SNFRY currently shows total debt of $1.51B and beta of 0.76. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.sinofert.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.